title: D3 receptor target engagement in humans with ABT-925 using [11C](+)-PHNO PET.
authors.affiliation: Global Pharmaceutical Research and Development, Translational Neuroimaging, Abbott, Abbott Park, IL60064, USA. mark.day@abbott.com
authors.forename: Mark
authors.initials: M
authors.lastname: Day
authors.forename: Earle
authors.initials: E
authors.lastname: Bain
authors.forename: Gerard
authors.initials: G
authors.lastname: Marek
authors.forename: Mario
authors.initials: M
authors.lastname: Saltarelli
authors.forename: Gerard B
authors.initials: GB
authors.lastname: Fox
mesh_terms: D001921:Brain / Q000000981:diagnostic imaging* / Q000187:drug effects; D006801:Humans; D010078:Oxazines / Q000493:pharmacokinetics*; D049268:Positron-Emission Tomography / Q000379:methods*; D050637:Receptors, Dopamine D3 / Q000037:antagonists & inhibitors* / Q000378:metabolism*
chemical_list: D010078:Oxazines; D050637:Receptors, Dopamine D3; C042631:naxagolide